Suchergebnisse - "Kelley, R K"

PubPharm (16)

1

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

2

Biliary tract cancer : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Vogel, A. | Bridgewater, J. | Edeline, J. | +9

CommentIn: Ann Oncol. 2023 Jun;34(6):555-556. - PMID 36813114

3

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Berchuck, J. | Facchinetti, F. | DiToro, D. | +26

CommentIn: Ann Oncol. 2022 Dec;33(12):1209-1211. - PMID 36182024

4

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

enthalten in: Clinical and translational gastroenterology | 2019

von Kelley, R. | Gane, E. | Assenat, E. | +11

5

Cabozantinib in hepatocellular carcinoma : results of a phase 2 placebo-controlled randomized discontinuation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Kelley, R. | Verslype, C. | Cohn, A. | +9

CommentIn: Ann Oncol. 2017 Mar 1;28(3):450-451. - PMID 28137742

6

Cabozantinib in Hepatocellular Carcinoma: Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Study

enthalten in: Annals of oncology | 2017

von Kelley, R. | Verslype, C. | Cohn, A. | +9

7

A phase II study of axitinib in advanced neuroendocrine tumors

enthalten in: Endocrine-related cancer | 2016

von Strosberg, J. | Cives, M. | Hwang, J. | +9

8

A phase II study of axitinib in advanced neuroendocrine tumors

enthalten in: Endocrine related cancer | 2016

von Strosberg, J. | Cives, M. | Hwang, J. | +9

9

Radioembolization with 490Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study

enthalten in: Journal of vascular and interventional radiology | 2015

von Fidelman, N. | Kerlan, R. | Taylor, A. | +14

10

A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors

enthalten in: Clinical cancer research | 2015

von Papadopoulos, K. | Kelley, R. | Tolcher, A. | +14